An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study

Introduction: Patients with stage III NSCLC represent a very heterogenous group that requires different treatment strategies, especially in patients with N2 (2 nearby lymph nodes having cancer)-positive NSCLC and unresectable EGFR-mutant NSCLC. This real-world study may provide more insights into tr...

Full description

Bibliographic Details
Main Authors: Po-Lan Su, MD, Gee-Chen Chang, MD, Shih-Hsin Hsiao, MD, Te-Chun Hsia, MD, Meng-Chih Lin, MD, Min-Hsi Lin, MD, Jin-Yuan Shih, MD, Cheng-Ta Yang, MD, Sheng-Hsiung Yang, MD, Yuh-Min Chen, MD, PhD
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:JTO Clinical and Research Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322000169